Healthcare provider profile · identity verified

Stephen D Conrad, MD

Internal Medicine · MEDIA, PA · NPI 1477643609

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	509	109
Atorvastatin Calcium	Atorvastatin Calcium	466	119
Levothyroxine Sodium	Levothyroxine Sodium	281	51
Rosuvastatin Calcium	Rosuvastatin Calcium	272	66
Gabapentin	Gabapentin	263	71
Metoprolol Succinate	Metoprolol Succinate	259	58
Omeprazole	Omeprazole	244	57
Hydrochlorothiazide	Hydrochlorothiazide	232	60
Eliquis	Apixaban	231	36
Lisinopril	Lisinopril	223	52
Furosemide	Furosemide	205	37
Famotidine	Famotidine	175	41
Potassium Chloride	Potassium Chloride	151	28
Sertraline Hcl	Sertraline Hcl	149	27
Tramadol Hcl	Tramadol Hcl	145	40
Metformin Hcl	Metformin Hcl	144	31
Losartan Potassium	Losartan Potassium	129	35
Montelukast Sodium	Montelukast Sodium	124	26
Terazosin Hcl	Terazosin Hcl	119	18
Tamsulosin Hcl	Tamsulosin Hcl	112	21
Simvastatin	Simvastatin	111	22
Pravastatin Sodium	Pravastatin Sodium	104	18
Trazodone Hcl	Trazodone Hcl	98	14
Alendronate Sodium	Alendronate Sodium	91	28
Duloxetine Hcl	Duloxetine Hcl	84	20
Escitalopram Oxalate	Escitalopram Oxalate	84	19
Metoprolol Tartrate	Metoprolol Tartrate	84	18
Pantoprazole Sodium	Pantoprazole Sodium	83	22
Fluticasone Propionate	Fluticasone Propionate	78	26
Ezetimibe	Ezetimibe	77	12
Prednisone	Prednisone	74	26
Latanoprost	Latanoprost	72	11
Albuterol Sulfate Hfa	Albuterol Sulfate	70	27
Carvedilol	Carvedilol	69	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	66	suppressed
Valsartan	Valsartan	64	21
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	64	17
Lorazepam	Lorazepam	63	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	61	17
Spironolactone	Spironolactone	56	suppressed
Januvia	Sitagliptin Phosphate	55	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	55	14
Finasteride	Finasteride	52	suppressed
Jardiance	Empagliflozin	50	13
Glipizide Er	Glipizide	49	suppressed
Levetiracetam	Levetiracetam	46	suppressed
Donepezil Hcl	Donepezil Hcl	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Warfarin Sodium	Warfarin Sodium	42	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	12
Metformin Hcl Er	Metformin Hcl	39	11
Mirtazapine	Mirtazapine	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	suppressed
Myrbetriq	Mirabegron	38	suppressed
Atenolol	Atenolol	37	suppressed
Ibandronate Sodium	Ibandronate Sodium	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Cyclosporine	Cyclosporine	32	suppressed
Allopurinol	Allopurinol	30	11
Buspirone Hcl	Buspirone Hcl	30	suppressed
Irbesartan	Irbesartan	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	23
Hydromorphone Hcl	Hydromorphone Hcl	29	suppressed
Ipratropium Bromide	Ipratropium Bromide	29	11
Bupropion Xl	Bupropion Hcl	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Nystatin	Nystatin	27	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Timolol Maleate	Timolol Maleate	24	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	21	suppressed
Folic Acid	Folic Acid	21	suppressed
Ozempic	Semaglutide	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Zenpep	Lipase/Protease/Amylase	19	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Cilostazol	Cilostazol	17	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Estradiol	Estradiol	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Minoxidil	Minoxidil	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Gemtesa	Vibegron	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Sulfasalazine Dr	Sulfasalazine	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Travoprost	Travoprost	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error